EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Late-Course Adjuvant Radiotherapy Concurrent with CDK4/6 Inhibitor for High-risk Breast Cancer: A Single -Center Randomized Controlled Trial Study

Yang Hui, Zhang Yanxian, Tao Nana, Zhu Yanqing, Lu Ying

Clinical Breast Cancer · 2026-11

DOI: 10.1016/j.clbc.2026.10.017 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Clinical Breast Cancer, 2026-11. Verfasst von Yang Hui und 4 weiteren Autor:innen. Die Arbeit nennt 30 Literaturangaben. Gefördert von: Guangxi Zhuang Region Health and Family Planning Commission.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Förderung

  • Guangxi Zhuang Region Health and Family Planning Commission

Zitieren

APA

Hui, Y., Yanxian, Z., Nana, T., Yanqing, Z., & Ying, L. (2026). Late-Course Adjuvant Radiotherapy Concurrent with CDK4/6 Inhibitor for High-risk Breast Cancer: A Single -Center Randomized Controlled Trial Study. Clinical Breast Cancer. https://doi.org/10.1016/j.clbc.2026.10.017

Vancouver

Hui Y, Yanxian Z, Nana T, Yanqing Z, Ying L. Late-Course Adjuvant Radiotherapy Concurrent with CDK4/6 Inhibitor for High-risk Breast Cancer: A Single -Center Randomized Controlled Trial Study. Clinical Breast Cancer. 2026. doi:10.1016/j.clbc.2026.10.017

BibTeX
@article{Hui2026,
  author = {Hui, Yang and Yanxian, Zhang and Nana, Tao and Yanqing, Zhu and Ying, Lu},
  title = {Late-Course Adjuvant Radiotherapy Concurrent with CDK4/6 Inhibitor for High-risk Breast Cancer: A Single -Center Randomized Controlled Trial Study},
  journal = {Clinical Breast Cancer},
  year = {2026},
  doi = {10.1016/j.clbc.2026.10.017}
}
Kostenlos starten →